Swiss biotech CFO meeting
Venture financing - removing hurdles and increasing sources of liquidity
Monday, November 18, 2024, 9:30 - 14:00
SIX Swiss Exchange, Pfingstweidstrasse 110, 8021 Zürich
Last year, the Swiss Biotech Association successfully hosted the first Swiss biotech CFO meeting to connect and collaborate.
In this relaxed and interactive setting, you are encouraged to openly share and discuss your current view on venture financing.
We exchange ideas, share valuable experiences, and collaboratively shape the ideal framework conditions to raise financial resources and enable partnering for biotechs.
You will not receive a separate confirmation of your attendance.
Program
9:30 – 10:30
Doors open, coffee, welcome by the Swiss Biotech Association
Keynote: challenges and opportunities in the private financing market
by Philipp Gutzwiller, Managing Partner, CFS Advisors
10:30 – 11:10
Hurdles in financing and how to address them
Panel discussion and Q&A moderated by Philipp Gutzwiler
- Tatjana Bauecker, CFO, Newbiologix
- Ralf Rosenow, Legal Counsel & Secretary to the BoD, Cutiss
- Daniel Häusermann, Partner, Homburger
- Urs Breitenstein, Partner, Hoffmann & Partner
11:10 – 11:50
Is private debt the right solution?
Panel discussion and Q&A moderated by Philipp Gutzwiler
- Markus Ehrler, Partner, Marlborough Partners
- Andrew Smith, CFO, Santhera Pharmaceuticals
- Julien Michaux, Investment Management, Hayfin Capital Management
11:50 – 12:30
Beyond venture capital funds
Panel discussion and Q&A moderated by Philipp Gutzwiler
- Søren Bjønness, Director Capital Advisory, Deloitte
- Rory Pope, Partner, Apposite Capital
- Riccardo Braglia, Executive Chairman, 3B Future Health Fund
- Michio Painter, Head UMZH Translational Medicine Accelerator, University of Zurich
12:30 – 14:00
Networking Lunch
Join us for this inspiring exchange and register before October 15
